This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Vulvovaginal Candidiasis
and you are
between 18 and 49
years old
1
2
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The present study aims to evaluate the safety of two mucoadhesive gels containing a propolis standardized extract identified as EPP-AF, with 1 and 2% of propolis. The efficacy studies with both propolis gels will be performed in comparison with clotrimazole cream in patients presenting vulvovaginal candidiasis.

Provided treatments

  • Drug: EPP-AF Gel 1%
  • Drug: EPP-AF Gel 2%
  • Drug: Clotrimazole
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03024502. The sponsor of the trial is University of Sao Paulo and it is looking for 90 volunteers for the current phase.
Official trial title:
Randomized Clinical Trial of a Mucoadhesive Gel Containing EPP-AF in Patients Diagnosed With Vulvovaginal Candidiasis